Key Insights

Highlights

Treatment Research

5 treatments under study, led by Enoxaparina Rovi 10000 Ui 100 Mg1 Ml Solución Inyectable En Jeringa Precargada

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

0.0%

0 terminated out of 1 trials

Late-Stage Pipeline

100%

1 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

1Total
Phase 3 (1)

Trial Status

Recruiting1

Clinical Trials (1)

Showing 1 of 1 trials
SYFecb34d1773c0466b836721876bf33e52Phase 3Recruiting

Study to evaluate the efficacy and safety of enoxaparin in children with slow-flow vascular problems undergoing interventional procedures

Showing all 1 trials

Research Network

Common Treatments

  • Enoxaparina Rovi 10000 Ui 100 Mg1 Ml Solución Inyectable En Jeringa Precargada1
  • Enoxaparina Rovi 4000 Ui 40 Mg04 Ml Solución Inyectable En Jeringa Precargada1
  • Enoxaparina Rovi 6000 Ui 60 Mg06 Ml Solución Inyectable En Jeringa Precargada1
  • Enoxaparina Rovi 8000 Ui 80 Mg08 Ml Solución Inyectable En Jeringa Precargada1
  • Enoxaparina Rovi 2000 Ui 20 Mg02 Ml Solución Inyectable En Jeringa Precargada1

Active Sponsors

  • Fundacio Sant Joan De Deu1

Activity Timeline